DCEG Participates in 2018 AACR Annual Meeting
, by DCEG Staff
In April 2018, several DCEG staff members took part in the annual meeting of the American Association for Cancer Research (AACR) in Chicago, Illinois. This five-day event highlighted the latest scientific advances in basic, clinical, and epidemiologic cancer research. The theme of this year's meeting was "Driving Innovative Cancer Science to Patient Care."
Minkyo Song, M.D., Ph.D., was awarded an Excellent Young Researcher certificate from the journal Antibodies for her poster, "Associations of polyomavirus seroreactivity with AIDS-related non-Hodgkin's lymphoma."
Ruth Pfeiffer, Ph.D., spoke at an educational session about "Old and new puzzles in the genetic epidemiology of cancer." Her talk was titled "Clinical utility of cancer risk models: What to expect from polygenic risk scores."
Michael B. Cook, Ph.D., chaired a session on "Genetic and molecular epidemiology of cancer risk and prognosis." Three DCEG staff presented research at this session: Lisa Mirabello, Ph.D., M.S., on "A genome-wide scan identifies a new locus associated with pediatric rhabdomyosarcoma," Mitchell J. Machiela, Sc.D., M.P.H., on "Multiple new susceptibility loci identified in genome-wide association study of Ewing sarcoma," and Mustapha Abubakar, M.D., Ph.D., on "Digital image analysis based IHC4+C assay and prognosis in hormone receptor-positive breast cancer."
Nicolas Wentzensen, M.D., Ph.D., hosted a meet-the-expert session on "Population Perspectives on Ovarian Cancer: What Is New in Etiology, Screening and Prevention?"
Montserrat García-Closas, M.D., Dr.P.H., discussed "Identification of women susceptible to aggressive vs non-aggressive breast cancer subtypes, and implications for screening/prevention" during a session titled "Distinguishing Aggressive from Nonaggressive Lesions: Foundations for Cancer Prevention."
Britton Trabert, Ph.D., M.S., spoke about her work on "Serologic markers of infectious agents and ovarian cancer: Markers of prior Chlamydia trachomatis infection associated with increased ovarian cancer risk in two independent populations" at a session on "Endogenous and Exogenous Factors in Cancer Risk and Mortality." During this same session, Jonathan Hofmann, Ph.D., M.P.H., presented "Circulating immunologic markers and risk of multiple myeloma and its precursor disease: A nested case-control study."
DCEG scientists and fellows also presented almost 30 posters.